Evidence map›Paper›PMID 19649276›Full record

ArticlePLoS pathogens2009

The two-domain LysX protein of Mycobacterium tuberculosis is required for production of lysinylated phosphatidylglycerol and resistance to cationic antimicrobial peptides.

Erin Maloney, Dorota Stankowska, Jian Zhang, Marek Fol, Qi-Jian Cheng, Shichun Lun, William R Bishai, Malini Rajagopalan, Delphi Chatterjee, Murty V Madiraju

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 111 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Frontiers in immunology · 2023
    Review
  12. Article
  13. SensitizingeLife · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Genetic Involvement ofInternational journal of molecular sciences · 2021
    Review
  18. Frontiers in cellular and infection microbiology · 2021
    Article
  19. Mutation onVirulence · 2020
    Article
  20. Small-Molecule Acetylation by GCN5-RelatedMicrobiology and molecular biology reviews : MMBR · 2020
    Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Erin MaloneyDepartment of Biochemistry, The University of Texas Health Center at Tyler, Tyler, TX, USA.
Dorota Stankowska
Jian Zhang
Marek Fol
Qi-Jian Cheng
Shichun Lun
William R Bishai
Malini Rajagopalan
Delphi Chatterjee
Murty V Madiraju
The University of Texas Health Science Center at Tyler · USJohns Hopkins University · USColorado State University · US

Funding

Mycobacterium tuberculosis Survival Regulatory GenesR01AI037856 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BISHAI, WILLIAM RAMSES · 1997 to 2020
$7.2M
GENE REGULATION AND VIRULENCE IN TB AND MACR01AI036973 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BISHAI, WILLIAM RAMSES · 1999 to 2014
$5.7M
Mycobacterium tuberculosis cell division and proliferationR01AI048417 · NIAID · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI RAJAGOPALAN, MALINI · 2000 to 2011
$3.0M
TB LAM AND AG--STRUCTURES CORRELATED WITH BIOLOGYR01AI037139 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · PI CHATTERJEE, DELPHI · 1996 to 2008
$1.5M
REPLICATION OF M AVIUM AND NOVEL DRUG TARGETSR01AI041406 · NIAID · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI MADIRAJU, MURTY V. · 1997 to 2007
$1.0M
Regulation of Mycobacterium tuberculosis proliferationR56AI073966 · NIAID · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI MADIRAJU, MURTY V. · 2008 to 2009
$700k
SUPERANTIGENS AND THE MHC--STRUCTURE/FUNCTIONR01AI030036 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI COOK, RICHARD G · 1991 to 2000
$343k
Structure of LAM in Relation to Biology and BiosynthesisR21AI037139 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · PI CHATTERJEE, DELPHI · 2002 to 2002
$244k
SEARCH FOR GENETIC REGULATORS OF LATENCY IN M TBR29AI036973 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BISHAI, WILLIAM RAMSES · 1994 to 1998
–
NIAID NIH HHS AI30036NIAID NIH HHS AI36973NIAID NIH HHS AI37139NIAID NIH HHS AI37856NIAID NIH HHS AI41406NIAID NIH HHS AI48417NIAID NIH HHS AI73966NIAID NIH HHS N01 AI030036NIAID NIH HHS R01 AI036973NIAID NIH HHS R01 AI037139NIAID NIH HHS R01 AI037856NIAID NIH HHS R01 AI041406NIAID NIH HHS R01 AI048417NIAID NIH HHS R21 AI037139NIAID NIH HHS R56 AI073966
6 · The paper itself

Abstract

The well-recognized phospholipids (PLs) of Mycobacterium tuberculosis (Mtb) include several acidic species such as phosphatidylglycerol (PG), cardiolipin, phosphatidylinositol and its mannoside derivatives, in addition to a single basic species, phosphatidylethanolamine. Here we demonstrate that an additional basic PL, lysinylated PG (L-PG), is a component of the PLs of Mtb H37Rv and that the lysX gene encoding the two-domain lysyl-transferase (mprF)-lysyl-tRNA synthetase (lysU) protein is responsible for L-PG production. The Mtb lysX mutant is sensitive to cationic antibiotics and peptides, shows increased association with lysosome-associated membrane protein-positive vesicles, and it exhibits altered membrane potential compared to wild type. A lysX complementing strain expressing the intact lysX gene, but not one expressing mprF alone, restored the production of L-PG and rescued the lysX mutant phenotypes, indicating that the expression of both proteins is required for LysX function. The lysX mutant also showed defective growth in mouse and guinea pig lungs and showed reduced pathology relative to wild type, indicating that LysX activity is required for full virulence. Together, our results suggest that LysX-mediated production of L-PG is necessary for the maintenance of optimal membrane integrity and for survival of the pathogen upon infection.

Indexed as

AnimalsAntimicrobial Cationic PeptidesBacterial ProteinsCytokinesDrug Resistance, BacterialFemaleGuinea PigsHumansLungLysineLysophospholipidsLysosomal-Associated Membrane Protein 1Lysosomal Membrane ProteinsMacrophagesMembrane PotentialsMiceAntimicrobial Cationic PeptidesBacterial ProteinsCytokinesLAMP1 protein, humanLysineLysophospholipidsLysosomal-Associated Membrane Protein 1Lysosomal Membrane ProteinsPhosphatidylglycerolsPhospholipids

Identifiers

PMID19649276
PMCPMC2713425
OpenAlexW2047686077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.